MedPath

The aim is to compare three medicines of which any one will be given to patient after surgery intraperitonealy to reduce pain , we shall then note pain level using a scoring method and their dose and time of administration.

Phase 4
Conditions
Health Condition 1: K800- Calculus of gallbladder with acutecholecystitis
Registration Number
CTRI/2024/01/061044
Lead Sponsor
SGT medical college hospital and research institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of either sex of ASA (American Society of Anaesthesiologists) grade I and II of 18-65 years for undergoing laparoscopic cholecystectomy.

Exclusion Criteria

Patients of ASA grade III, IV and V with presence of any psychiatric illness, heart disease, renal impairment and those with an allergy to any of the study drugs will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The ultimate vision is to improve post operative pain management to the point where pain after surgery can be prevented and managed most effectively.Timepoint: Postoperative pain will be assessed on arrival, 30 minutes, 1 hour, 2 hours, 6 hours and 24 hours.
Secondary Outcome Measures
NameTimeMethod
1. To study the effect of intraperitoneal magnesium sulphate on post operative pain based on visual analogue scoring. <br/ ><br>2. To study the effect of intraperitoneal bupivacaine on post operative pain based on visual analogue scoring. <br/ ><br>3. To study the effect of intraperitoneal magnesium sulphate and bupivacaine combination on post operative pain based on visual analogue scoring. <br/ ><br>4. To compare the time for first rescue analgesia and total consumption of the rescue analgesic tramadol during the first postoperative day with all the three modes as above.Timepoint: <br/ ><br>1 year
© Copyright 2025. All Rights Reserved by MedPath